Epidermal growth factor receptor blockers for the treatment of ovarian cancer
<p>Background: This is an update of a previously published version of the review (Issue 10, 2011).</p><p> Epithelial ovarian cancer (EOC) is the seventh most common cause of cancer death among women worldwide. Treatment consists of a combination of surgical debulking and pla...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
John Wiley & Sons, Ltd
2018
|